Zantac Lawsuit Attorney
Ranitidine, sold for decades under the brand name Zantac, was one of the most widely used heartburn medications in the world. What millions of patients were never told was that the drug could degrade into a known carcinogen, N-nitrosodimethylamine, or NDMA, under normal storage conditions and inside the human body. When independent researchers and the FDA confirmed this contamination problem, it triggered one of the largest pharmaceutical recall and litigation events in recent memory. People who took Zantac regularly for years and later developed certain cancers are now asking hard questions about whether the drug played a role, and many are pursuing legal claims against the manufacturers responsible for putting it on the market. If you or a family member used ranitidine and received a cancer diagnosis, consulting a Zantac lawsuit attorney is a step that can help you understand what your situation actually means under the law.
The litigation surrounding Zantac is complex in ways that go beyond typical product liability cases. It involves federal multidistrict litigation, state court filings, contested causation science, and pharmaceutical defendants with substantial legal resources. Florida courts have seen Zantac-related claims, and plaintiffs across South Florida, the Treasure Coast, and statewide have been working to evaluate whether their cancer diagnoses connect to years of ranitidine use. Getting the right legal representation from the start determines how well your claim is prepared, how evidence is developed, and what outcome becomes realistic.
Leifer & Ramirez represents injury victims and families throughout Florida who have been harmed by defective and dangerous pharmaceutical products. The firm’s background in dangerous drug cases means its attorneys understand both the medical complexity of these claims and what it actually takes to build a case against a pharmaceutical manufacturer that has every incentive to dispute liability.
What the Zantac NDMA Problem Actually Means for Your Case
NDMA is classified as a probable human carcinogen by the World Health Organization. It forms through chemical degradation, and ranitidine’s molecular structure makes it particularly prone to producing NDMA over time, especially when stored at elevated temperatures or when it breaks down inside the digestive system. The FDA ultimately concluded that NDMA levels in ranitidine products increase the longer the medication sits in storage and climb further when the drug is exposed to heat, which is unavoidable for products kept in medicine cabinets, pharmacies, or warehouses in warm climates like Florida.
For someone who took Zantac occasionally over a short period, the risk picture may look different than for someone who used it daily for years to manage chronic acid reflux, GERD, or ulcers. Long-term, regular users accumulated the greatest cumulative NDMA exposure, and those individuals are generally the focus of current litigation. The cancers most frequently associated with ranitidine exposure in litigation include bladder cancer, stomach cancer, esophageal cancer, colorectal cancer, kidney cancer, and liver cancer. Courts and litigation proceedings have evaluated causation evidence for each of these cancer types at different levels of scrutiny, which affects how claims are organized and which cases move forward.
Cancer Types and Claim Categories in Zantac Litigation
- Bladder Cancer: Research on NDMA and bladder cancer has been central to ranitidine litigation. Florida plaintiffs with bladder cancer diagnoses who used ranitidine regularly have been among those pursuing claims, given evidence that NDMA concentrates in urine and makes prolonged contact with bladder tissue.
- Stomach and Gastric Cancer: Because ranitidine breaks down in the gastrointestinal system, the stomach is directly exposed to NDMA degradation products. Gastric cancer claims have been filed by plaintiffs throughout Florida and nationally as part of broader Zantac lawsuits.
- Colorectal Cancer: The colon and rectum are downstream exposure points for NDMA generated by ranitidine metabolism. Colorectal cancer is among the cancer types evaluated by plaintiffs’ experts in federal MDL proceedings.
- Esophageal Cancer: Zantac was commonly prescribed for esophageal conditions including GERD and Barrett’s esophagus, meaning patients already at elevated esophageal cancer risk were often the heaviest users of the drug over extended periods.
- Kidney Cancer: NDMA exposure through the bloodstream creates risk for organs involved in filtration and excretion. Kidney cancer claims are part of the litigation landscape, particularly for plaintiffs with documented long-term ranitidine use.
- Liver Cancer: The liver metabolizes NDMA, and research has identified hepatotoxic effects associated with NDMA exposure. Liver cancer plaintiffs have pursued claims as part of the broader ranitidine litigation.
- Wrongful Death Claims: Families who lost a loved one to a ranitidine-linked cancer may have standing to pursue a wrongful death claim in Florida. These claims carry their own procedural requirements and deadlines distinct from individual personal injury filings.
Why Leifer & Ramirez for a Dangerous Drug Claim of This Scale
Pharmaceutical product liability cases require a legal team that has genuine experience holding companies accountable for defective and dangerous drugs, not just familiarity with car accident or slip-and-fall practice. Leifer & Ramirez has spent over 25 years representing Florida injury victims in complex matters, including cases involving defective medical devices, dangerous pharmaceuticals, and class action litigation. The firm handles cases involving defective drugs and medical devices as a dedicated practice area, meaning attorneys at Leifer & Ramirez have dealt with the kinds of causation arguments, expert witness battles, and manufacturer defenses that define pharmaceutical litigation.
The firm’s case results reflect what determined representation can accomplish even when liability is disputed and insurance companies or corporations initially deny responsibility. A $1,000,000 recovery in a slip and fall case where liability was originally denied, and a $350,000 wrongful death settlement where initial liability was refused, both illustrate that Leifer & Ramirez does not walk away from a defensible claim because a corporate defendant initially says no. In Zantac litigation, where pharmaceutical manufacturers have contested general causation aggressively, having attorneys who will develop a claim fully and press it through the process matters significantly. The firm operates on a contingency fee basis, meaning no fees or costs are charged unless money is recovered for the client. Offices in Boca Raton, Fort Lauderdale, West Palm Beach, and Port St. Lucie serve clients across the full South Florida region and the Treasure Coast.
What Florida Zantac Claimants Should Do Right Now
The most important thing a Florida resident with a potential Zantac claim can do immediately is gather documentation of ranitidine use and the cancer diagnosis. This means locating prescription records, pharmacy fill histories, and any over-the-counter purchase receipts or records if the medication was bought without a prescription. Pharmacies and healthcare providers can often pull fill histories going back years, so do not assume the records are lost simply because you do not have paper copies at home. Your oncologist, gastroenterologist, or primary care physician will have records of both the cancer diagnosis and any previous prescriptions for ranitidine or its generic equivalents.
Florida’s statute of limitations for product liability claims, including dangerous drug cases, creates real deadlines for filing. The clock generally starts running from the point of discovery, meaning when a claimant knew or reasonably should have known that their cancer might be connected to the drug. Given that public awareness of the Zantac-NDMA issue became widespread after the 2019 FDA warnings and 2020 full market recall, claimants who received diagnoses during or after that period need to move with urgency. Waiting significantly reduces the legal options available.
Zantac claims have been filed in both federal multidistrict litigation and state courts, including Florida state courts. The proper venue and filing strategy for a specific claim depends on when the diagnosis was made, which cancer type is involved, and the applicable evidence standards in that court system. A Zantac attorney at Leifer & Ramirez can assess which approach makes sense for a particular client’s situation, rather than applying a one-size approach to a case category where venue strategy genuinely affects outcomes. The Florida court system routes complex civil cases through circuit courts at the county level, and understanding how these cases move through Broward, Palm Beach, Martin, St. Lucie, and other South Florida counties is part of what local representation provides.
Questions About Zantac Cancer Claims
Who qualifies to file a Zantac lawsuit in Florida?
A person who used ranitidine, whether the brand-name Zantac or a generic version, for a sustained period and subsequently developed a cancer type associated with NDMA exposure may have a viable claim. The strongest cases generally involve regular, long-term use rather than occasional or short-term use, and a cancer diagnosis that came after that period of use. A family member filing a wrongful death claim on behalf of someone who died from a ranitidine-linked cancer may also have standing depending on Florida law requirements for such claims.
Which manufacturers are defendants in Zantac lawsuits?
Sanofi, GlaxoSmithKline, Pfizer, and Boehringer Ingelheim have all been named as defendants in ranitidine litigation at various points, along with pharmacy chains and distributors depending on the legal theory pursued. The specific defendants named in any individual case depend on who manufactured, distributed, and sold the drug the plaintiff used and during what time period.
Does it matter whether I used brand-name Zantac or a generic version?
The NDMA contamination issue applies to ranitidine itself, regardless of brand. Generic ranitidine products were recalled alongside brand-name Zantac. Claimants who used generic versions may have different defendant targets depending on who manufactured their specific product, but generic ranitidine use does not preclude a claim. Pharmacy records typically identify the specific manufacturer of a filled generic prescription.
What happened in the federal MDL and does it affect my individual claim?
A federal multidistrict litigation proceeding for Zantac cases was consolidated in the Southern District of Florida. Federal MDL courts have evaluated general causation evidence and in some proceedings issued rulings that affected how certain cancer types could proceed. Those rulings do not uniformly extinguish state court claims, and litigation has continued in various state courts. The status of federal MDL proceedings is something a Zantac lawsuit attorney would need to assess in the context of your specific diagnosis and claim before advising on strategy.
How long does a Zantac lawsuit typically take to resolve?
Mass tort pharmaceutical litigation does not move on a quick timeline. Settlement negotiations in large pharmaceutical cases often take years, and trial schedules in complex product liability matters can extend further. However, some cases settle individually, particularly as litigation matures and defendants evaluate the risk of individual verdicts. There is no uniform answer because outcomes depend on the strength of individual medical evidence, the cancer type involved, the applicable court’s docket, and the posture of the specific defendants named. A realistic attorney will give you honest expectations at the outset rather than promising a fast resolution.
I took Zantac for years but my cancer diagnosis was not on the commonly cited list. Can I still consult with your firm?
Yes. The cancer types most prominently featured in current litigation represent the most researched association with NDMA, but the scientific picture continues to evolve. If you used ranitidine regularly and developed cancer of any type, it is worth discussing with an attorney who can evaluate your situation against the current state of the science and litigation. A consultation does not commit you to filing a claim, and it costs you nothing to have your situation assessed.
What if I also have a pending health insurance or Medicare lien related to my cancer treatment?
Any recovery in a Zantac lawsuit may trigger lien rights from health insurers, Medicare, or Medicaid if those programs paid for cancer treatment. Florida law and federal law govern how these liens are handled in personal injury and product liability settlements. Proper lien resolution is part of the settlement process, and your attorney handles the identification and negotiation of these liens as part of closing a case. Failing to address liens correctly can create legal problems after a settlement, which is one reason working with attorneys experienced in pharmaceutical litigation matters.
Can I still file a claim if I have already finished cancer treatment and am in remission?
Yes. A Zantac claim does not require that cancer be active at the time of filing. The damages claimed in pharmaceutical product liability cases include the full scope of harm caused, including past medical expenses, the physical and emotional impact of the cancer diagnosis and treatment, lost wages during treatment, and long-term effects even if the cancer is currently in remission. Completed treatment does not eliminate the harm that was done.
What if a loved one who used Zantac has died and no estate has been opened in Florida?
A wrongful death claim in Florida requires that the estate of the deceased be the plaintiff, represented by a personal representative. If no estate has been opened, that step typically needs to happen before the claim can be formally filed. This is a procedural hurdle that attorneys handling these cases routinely assist families with navigating, and it should not deter someone from consulting an attorney. The important thing is to act before the statute of limitations closes on the potential claim.
What does it cost to pursue a Zantac lawsuit with Leifer & Ramirez?
Leifer & Ramirez handles dangerous drug cases on a contingency fee basis. There are no attorney fees or case costs charged unless the firm recovers money for you. This means clients do not pay out of pocket to have their claim investigated, developed, and pursued. The initial consultation is free and confidential, and you can discuss the specifics of your situation with the firm before making any decisions.
Zantac Lawsuit Representation Across South Florida and the Treasure Coast
Leifer & Ramirez represents Zantac claimants throughout Florida from offices in Boca Raton, Fort Lauderdale, West Palm Beach, and Port St. Lucie. In Palm Beach County, the firm serves clients in Boca Raton, Delray Beach, Boynton Beach, Lake Worth Beach, West Palm Beach, Palm Beach Gardens, Wellington, Jupiter, and the many communities that stretch across the county. In Broward County, the firm’s Fort Lauderdale office reaches clients in Hollywood, Pompano Beach, Deerfield Beach, Coral Springs, Plantation, Davie, Miramar, and Hallandale Beach. Northward along the Treasure Coast, the Port St. Lucie office serves clients in Stuart, Jensen Beach, Hobe Sound, Fort Pierce, and communities throughout Martin and St. Lucie counties. The firm also represents clients in Miami-Dade County and throughout central and northern Florida for matters of this nature. Wherever a Florida resident used ranitidine and received a cancer diagnosis, Leifer & Ramirez can discuss whether legal representation makes sense for their specific situation.
Talk to a Zantac Cancer Lawsuit Attorney at Leifer & Ramirez
A cancer diagnosis changes everything, and learning that the medication you trusted may have contributed to that diagnosis compounds an already difficult experience. The Zantac cancer lawsuit attorneys at Leifer & Ramirez work with Florida families who are trying to understand their legal options and decide whether to pursue a claim against the drug manufacturers responsible for putting ranitidine on the market without adequate warnings. The firm brings over 25 years of combined experience in Florida injury and product liability law to cases that require real investigation, scientific engagement, and persistent advocacy against well-funded corporate defendants. Consultations are free, confidential, and carry no obligation to proceed. Reach out to the firm today to have your situation evaluated and to understand what pursuing a Zantac lawsuit could mean for you and your family.
